Ginkgo Bioworks Holdings annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Debt-to-Equity Ratio Growth & History (DNA)
Ginkgo Bioworks Holdings's debt-to-equity ratio was 0.86 for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.86 | 0.21 | +32.40% |
| 2024 | 2024-12-31 | 0.65 | 0.43 | +195.85% |
| 2023 | 2023-12-31 | 0.22 | −0.03 | −13.67% |
| 2022 | 2022-12-31 | 0.26 | 0.24 | +1627.92% |
| 2021 | 2021-12-31 | 0.01 | −825.89 | −100.00% |
| 2020 | 2020-12-31 | 825.90 | — | — |
Ginkgo Bioworks Holdings quarterly debt-to-equity ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.96 | 0.26 | +37.44% |
| Q1 2026 | 2026-03-31 | 0.93 | 0.26 | +38.07% |
| Q4 2025 | 2025-12-31 | 0.86 | 0.21 | +32.40% |
| Q3 2025 | 2025-09-30 | 0.76 | 0.20 | +35.28% |
| Q2 2025 | 2025-06-30 | 0.70 | 0.16 | +28.87% |
| Q1 2025 | 2025-03-31 | 0.67 | 0.43 | +182.59% |
| Q4 2024 | 2024-12-31 | 0.65 | 0.43 | +195.85% |
| Q3 2024 | 2024-09-30 | 0.56 | 0.24 | +73.30% |
| Q2 2024 | 2024-06-30 | 0.54 | 0.27 | +98.64% |
| Q1 2024 | 2024-03-31 | 0.24 | −0.01 | −5.51% |
| Q4 2023 | 2023-12-31 | 0.22 | −0.03 | −13.67% |
| Q3 2023 | 2023-09-30 | 0.32 | 0.28 | +672.58% |
| Q2 2023 | 2023-06-30 | 0.27 | 0.24 | +714.13% |
| Q1 2023 | 2023-03-31 | 0.25 | 0.23 | +1355.06% |
| Q4 2022 | 2022-12-31 | 0.26 | 0.24 | +1627.92% |
| Q3 2022 | 2022-09-30 | 0.04 | 0.03 | +297.80% |
| Q2 2022 | 2022-06-30 | 0.03 | — | — |
| Q1 2022 | 2022-03-31 | 0.02 | — | — |
| Q4 2021 | 2021-12-31 | 0.01 | −825.89 | −100.00% |
| Q3 2021 | 2021-09-30 | 0.01 | — | — |
| Q4 2020 | 2020-12-31 | 825.90 | — | — |
Ginkgo Bioworks Holdings debt-to-equity ratio trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's debt-to-equity ratio decreased from 825.90 to 0.86, a change of −825.04. The latest reported quarter, Q2 2026, shows 0.96.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...